Publications by authors named "F Benini"

Optimal immune function is crucial in preventing cancer development and growth and for the success of anti-cancer therapies. Here, we characterized the peripheral immunological status of 83 steroids-naïve pediatric patients with central nervous system neoplasia at the disease onset. Tumors were classified into low-grade gliomas (LGG), high-grade gliomas (HGG), medulloblastoma, and other tumors.

View Article and Find Full Text PDF

Objective: To compare DuoStim versus a conventional approach in patients indicated to Preimplantation-Genetic-Testing for both monogenic conditions and aneuploidies (PGT-M + PGT-A).

Study Design: Retrospective case-control study. In 5 years, 132 couples indicated to PGT-M + PGT-A who obtained ≤5 blastocysts after a first retrieval were suggested to undergo a second stimulation in the same ovarian cycle.

View Article and Find Full Text PDF

Background: In pediatric palliative care, the main caregiver is primarily responsible for managing pharmaceutical therapies. Few data are available regarding the influence of this burden on quality of life in terms of time, concerns as well as a considerable risk of administration errors and adverse effects. This study aims to investigate how caregivers prepared and administrated medication, including errors and associated expectations, to identify improvement interventions.

View Article and Find Full Text PDF
Article Synopsis
  • Blinatumomab shows strong effectiveness in treating relapsed or refractory B-cell acute lymphoblastic leukemia (B-ALL) in children and young adults, often leading to hematopoietic stem cell transplantation (HSCT).
  • In a study with 78 patients, the 2-year disease-free survival (DFS) was 72.2% and overall survival (OS) was 89.2%, with low non-relapse mortality at 2.6%.
  • Patients who were in first complete remission had better DFS compared to those in later remissions, and those receiving both inotuzumab and blinatumomab had lower relapse rates post-HSCT.
View Article and Find Full Text PDF

Aplastic anaemia in infants and young children presents unique challenges due to high prevalence of inherited bone marrow failure syndromes (IBMFS) in this age group. The objective of this study is assessing clinical characteristics and outcomes of haematopoietic cell transplantation in children ≤5 years with bone marrow failure syndromes. We analysied 106 patients (66% males), median age 4.

View Article and Find Full Text PDF